These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 12200368

  • 1. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa.
    Bougie DW, Wilker PR, Wuitschick ED, Curtis BR, Malik M, Levine S, Lind RN, Pereira J, Aster RH.
    Blood; 2002 Sep 15; 100(6):2071-6. PubMed ID: 12200368
    [Abstract] [Full Text] [Related]

  • 2. Thrombocytopenia associated with the use of GPIIb/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb/IIIa inhibitors.
    Aster RH, Curtis BR, Bougie DW, Dunkley S, Greinacher A, Warkentin TE, Chong BH, Scientific and Standardization Committee of The International Society On Thrombosis and Haemostasis.
    J Thromb Haemost; 2006 Mar 15; 4(3):678-9. PubMed ID: 16460451
    [No Abstract] [Full Text] [Related]

  • 3. Thrombocytopenia following treatment with platelet glycoprotein IIb/IIIa inhibitors.
    Christopoulos CG.
    Blood; 2003 Feb 15; 101(4):1655; author reply 1655. PubMed ID: 12560245
    [No Abstract] [Full Text] [Related]

  • 4. Thrombocytopenia after treatment with platelet glycoprotein IIb/IIIa inhibitors.
    Abrams CS, Cines DB.
    Curr Hematol Rep; 2004 Mar 15; 3(2):143-7. PubMed ID: 14965491
    [Abstract] [Full Text] [Related]

  • 5. Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin.
    Bougie DW, Rasmussen M, Zhu J, Aster RH.
    Blood; 2012 Jun 28; 119(26):6317-25. PubMed ID: 22490676
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment.
    Tcheng JE.
    Am Heart J; 2000 Feb 28; 139(2 Pt 2):S38-45. PubMed ID: 10650315
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Abciximab pharmacodynamics are unaffected by antecedent therapy with other GPIIb/IIIa antagonists in non-human primates.
    Nakada MT, Sassoli PM, Tam SH, Nedelman MA, Jordan RE, Kereiakes DJ.
    J Thromb Thrombolysis; 2002 Aug 28; 14(1):15-24. PubMed ID: 12652146
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [GPIIb-IIIa inhibitors].
    Nurden P.
    Transfus Clin Biol; 2001 Apr 28; 8(2):114-22. PubMed ID: 11386043
    [Abstract] [Full Text] [Related]

  • 16. Monitoring platelet function in glycoprotein IIB/IIIA inhibitor therapy.
    Wu KK, Willerson JT.
    Circulation; 2001 May 29; 103(21):2528-30. PubMed ID: 11382717
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tirofiban and eptifibatide treatment of patients presenting with acute coronary syndrome with non-ST segment elevation.
    Corominas N, Perez J, Ortiz J, Ferrer E, Ribas J, Sanz G.
    Pharm World Sci; 2004 Feb 29; 26(1):38-43. PubMed ID: 15018258
    [Abstract] [Full Text] [Related]

  • 20. [Acute profound thrombocytopenia associated with tirofiban: clinical approach to diagnosis and therapeutic management].
    Agnelli D, Ottani F.
    G Ital Cardiol (Rome); 2008 Feb 29; 9(2):137-43. PubMed ID: 18383777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.